Ru Wen

Postdoctoral researcher at Stanford University, prostate and kidney cancer biology, prostate cancer immunotherapy, Siglec immune checkpoints.

[Ru Wen @Ru_M_Wen]

Team work makes dreams come true! # PCFRetreat25

[Ru Wen @Ru_M_Wen]

@CarolynBertozzi Thank you so much, Dr. Bertozzi. It has been a true pleasure to work with you and your lab. I have gained invaluable insights into Siglec immune checkpoints and their potential in immunotherapy. I look forward to exploring this exciting area further.

[Ru Wen @Ru_M_Wen]

My first commentary is out. I am happy to share the commentary on our recent publication of identifying AZGP1 as negative regulator for angiogenesis in prostate cancer. Thanks for my mentor Prof. James Brooks and Dr Hongjuan Zhao.

https://t.co/pBXoPJBz6T

[Ru Wen @Ru_M_Wen]

Excited to share our new article on AZGP1 as a negative regulator of angiogenesis in prostate cancer. Thank you to all of my colleagues for this great result!
https://t.co/wVkcyv8pji